1
|
Pan B, Hao Z, Zhou Y, Sun Q, Huo L. Increased 18 F-Fluoroestradiol Uptake of Radiation Pneumonitis in a Patient With Metastatic Breast Cancer. Clin Nucl Med 2023; 48:437-438. [PMID: 36800243 DOI: 10.1097/rlu.0000000000004609] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
Abstract
ABSTRACT A 42-year-old woman diagnosed with de-novo stage IV breast cancer underwent 18 F-fluoroestradiol (FES) PET/CT to evaluate the estrogen receptor status of metastatic lesions. The largest pulmonary nodule showed obvious FES uptake, consistent with pulmonary metastases from breast cancer. Interestingly, the images revealed a striking accumulation of FES in ground-glass attenuation in the left lobe of lung, suggestive of radiation pneumonitis.
Collapse
Affiliation(s)
- Bo Pan
- From the Department of Breast Surgery, Peking Union Medical College Hospital
| | - Zhixin Hao
- Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Center for Rare Diseases Research, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Yidong Zhou
- From the Department of Breast Surgery, Peking Union Medical College Hospital
| | - Qiang Sun
- From the Department of Breast Surgery, Peking Union Medical College Hospital
| | - Li Huo
- Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Center for Rare Diseases Research, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| |
Collapse
|
2
|
Qin X, Wang S, Liu X, Duan J, Cheng K, Mu Z, Jia J, Wei Y, Yuan S. Diagnostic Value of 18F-NOTA-FAPI PET/CT in a Rat Model of Radiation-Induced Lung Damage. Front Oncol 2022; 12:879281. [PMID: 35719937 PMCID: PMC9201039 DOI: 10.3389/fonc.2022.879281] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2022] [Accepted: 05/03/2022] [Indexed: 11/17/2022] Open
Abstract
In this study, we explore the diagnostic value of a novel PET/CT imaging tracer that specifically targets fibroblast activation protein (FAP), 18F-NOTA-FAPI, in a radiation induced lung damage (RILD) rat model. High focal radiation (40, 60, or 90 Gy) was administered to a 5-mm diameter area of the right lung in Wistar rats for evaluation of RILD induction. Lung tissues exposed to 90 Gy radiation were scanned with 18F-NOTA-FAPI PET/CT and with 18F-FDG. Dynamic 18F-NOTA-FAPI PET/CT scanning was performed on day 42 post-irradiation. After in vivo scanning, lung cryosections were prepared for autoradiography, hematoxylin and eosin (HE) and immunohistochemical (IHC) staining. An animal model of RILD was established and validated by histopathological analysis. On 18F-NOTA-FAPI PET/CT, RILD was first observed on days 42, 35 and 7 in the 40, 60 and 90 Gy groups, respectively. After treatment with 90 Gy, 18F-NOTA-FAPI uptake in an area of RILD emerged on day 7 (0.65 ± 0.05%ID/ml) and reappeared on day 28 (0.81 ± 0.09%ID/ml), remaining stable for 4–6 weeks. Autoradiography and HE staining IHC staining revealed that 18F-NOTA-FAPI accumulated mainly in the center of the irradiated area. IHC staining confirmed the presence of FAP+ macrophages in the RILD area, while FAP+ fibroblasts were observed in the peripheral area of irradiated lung tissue. 18F-NOTA-FAPI represents a promising radiotracer for in vivo imaging of RILD in a dose- and time-dependent manner. Noninvasive imaging of FAP may potentially aiding in the clinical management of radiotherapy patients.
Collapse
Affiliation(s)
- Xueting Qin
- Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
| | - Shijie Wang
- Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
| | - Xiaoli Liu
- Shandong Cancer Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Jinghao Duan
- Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
| | - Kai Cheng
- Department of PET/CT Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
| | - Zhengshuai Mu
- Department of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
| | - Jing Jia
- Shandong Cancer Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Yuchun Wei
- Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
| | - Shuanghu Yuan
- Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.,Shandong Cancer Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
| |
Collapse
|
3
|
Lombardi AF, Wong JH, High R, Ma Y, Jerban S, Tang Q, Du J, Frost P, Pagel MD, Chang EY. AcidoCEST MRI Evaluates the Bone Microenvironment in Multiple Myeloma. Mol Imaging Biol 2021; 23:865-873. [PMID: 33939066 PMCID: PMC8563482 DOI: 10.1007/s11307-021-01611-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2021] [Revised: 04/14/2021] [Accepted: 04/26/2021] [Indexed: 01/29/2023]
Abstract
PURPOSE Multiple myeloma (MM) is an incurable disease of malignant plasma cells in the bone marrow (BM). Adaptive responses to hypoxia may be an essential element in MM progression and drug resistance. This metabolic adaptation involves a decrease in extracellular pH (pHe), and it depends on the upregulation of glucose transporters (GLUTs) that is common in hypoxia and in cancer cells. CEST MRI is an imaging technique that assesses pHe indirectly by the exchange rate of magnetic saturation transfer between labile protons on a solute and water. Thus, this study aimed to determine the feasibility of acidoCEST MRI for pHe measurement using an orthotopic mouse model of MM compared with GLUT1 immunofluorescence staining as a reference. PROCEDURES Orthotopic BM engrafted MM xenografts were established in NSG/NOD mice using the human RPMI8226 myeloma cell line. AcidoCEST MRI was performed approximately 6 weeks after intravenous challenge, before and after intravenous administration of iopamidol. BM pHe values were generated via fitting the CEST spectrum with the Bloch-McConnell equations. Samples were decalcified, sectioned, and immunostained for GLUT1 expression. Pearson's correlation was used to assess the relationship between pHe and [H3O+] versus GLUT1 expression. RESULTS Ten mice underwent acidoCEST MRI followed by immunofluorescent histologic analysis. A strong negative correlation was seen between pHe versus GLUT1 expression (r = - 0.75, p < 0.001). After transformation of pH to [H3O+], a strong positive correlation between [H3O+] and GLUT1 expression was observed (r = 0.8, p < 0.001). CONCLUSIONS AcidoCEST MRI can measure the extracellular pH of bone marrow affected by multiple myeloma. In this MM orthotopic mouse model, pHe measured by acidoCEST MRI showed strong correlations with the metabolic phenotype of BM tumor assessed by immunofluorescent histological assessment of GLUT1 overexpression.
Collapse
Affiliation(s)
- Alecio F Lombardi
- Research Service, VA San Diego Healthcare System, 3350 La Jolla Village Drive, CA, 92161, San Diego, USA
- Department of Radiology, University of California, San Diego, CA, USA
| | - Jonathan H Wong
- Research Service, VA San Diego Healthcare System, 3350 La Jolla Village Drive, CA, 92161, San Diego, USA
- Department of Radiology, University of California, San Diego, CA, USA
| | - Rachel High
- Research Service, VA San Diego Healthcare System, 3350 La Jolla Village Drive, CA, 92161, San Diego, USA
- Department of Radiology, University of California, San Diego, CA, USA
| | - Yajun Ma
- Research Service, VA San Diego Healthcare System, 3350 La Jolla Village Drive, CA, 92161, San Diego, USA
- Department of Radiology, University of California, San Diego, CA, USA
| | - Saeed Jerban
- Research Service, VA San Diego Healthcare System, 3350 La Jolla Village Drive, CA, 92161, San Diego, USA
- Department of Radiology, University of California, San Diego, CA, USA
| | - Qingbo Tang
- Research Service, VA San Diego Healthcare System, 3350 La Jolla Village Drive, CA, 92161, San Diego, USA
- Department of Radiology, University of California, San Diego, CA, USA
| | - Jiang Du
- Research Service, VA San Diego Healthcare System, 3350 La Jolla Village Drive, CA, 92161, San Diego, USA
- Department of Radiology, University of California, San Diego, CA, USA
| | - Patrick Frost
- Research Service, Greater Los Angeles Veteran Administration Healthcare System, Los Angeles, CA, USA
- Department of Medicine, University of California, Los Angeles, CA, USA
| | - Mark D Pagel
- Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Eric Y Chang
- Research Service, VA San Diego Healthcare System, 3350 La Jolla Village Drive, CA, 92161, San Diego, USA.
- Department of Radiology, University of California, San Diego, CA, USA.
| |
Collapse
|